1 June 2008

Contents

Antiretrovirals

• Abacavir, ddI and risk of heart attack: additional published data and statements from the EMEA and FDA

Paediatric care

• US paediatric guidelines updated (2008)

• New paediatric dosing recommendations for atazanavir

Basic science and immunology

• Understanding control of HIV replication in the absence of therapy

• A surreal, deeply troubling week for AIDS vaccine research

Other news

• IAS calls for immediate release of Chinese activist

• Thailand’s war on drugs will undermine national AIDS fight and human rights: police given licence to kill drug users

• Activists criticise AIDS conference on opening day: Russian ban on substitution drug treatment is an ‘Iron Curtain’ to ARV treatment

• Opportunities for healthcare workers to volunteer overseas

On the web

• Conference reports and abstracts: 9th International Workshop on Clinical Pharmacology of HIV Therapy and 6th European HIV Drug Resistance Workshop

• New UK support group for gay men with HIV/HCV coinfection

• HCV pipeline report

• IHRD Harm Reduction Report

• TB – Online medical resources

• Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk

PDFs

• Volume 9 Number 5/6 May/June 2008 PDF